Diagnosis and management of transfusion iron overload: the role of imaging
- PMID: 17963249
- PMCID: PMC2892928
- DOI: 10.1002/ajh.21099
Diagnosis and management of transfusion iron overload: the role of imaging
Abstract
The characterization of iron stores is important to prevent and treat iron overload. Serum markers such as ferritin, serum iron, iron binding capacity, transferrin saturation, and nontransferrin-bound iron can be used to follow trends in iron status; however, variability in these markers limits predictive power for any given individual. Liver iron represents the best single marker of total iron balance. Measures of liver iron include biopsy, superconducting quantum interference device, computer tomography, and magnetic resonance imaging (MRI). MRI is the most accurate and widely available noninvasive tool to assess liver iron. The main advantages of MRI include a low-rate of variability between measurements and the ability to assess iron loading in endocrine tissues, the heart and the liver. This manuscript describes the principles, validation, and clinical utility of MRI for tissue iron estimation.
2007 Wiley-Liss, Inc
Figures


Similar articles
-
Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.Eur J Haematol. 2015 May;94(5):404-12. doi: 10.1111/ejh.12444. Epub 2014 Oct 18. Eur J Haematol. 2015. PMID: 25200112
-
Guidelines for quantifying iron overload.Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):210-5. doi: 10.1182/asheducation-2014.1.210. Epub 2014 Nov 18. Hematology Am Soc Hematol Educ Program. 2014. PMID: 25696857 Review.
-
Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia.Acta Med Indones. 2018 Jul;50(3):230-236. Acta Med Indones. 2018. PMID: 30333273
-
Role of liver magnetic resonance imaging in hyperferritinaemia and the diagnosis of iron overload.Swiss Med Wkly. 2017 Nov 8;147:w14550. doi: 10.4414/smw.2017.14550. eCollection 2017. Swiss Med Wkly. 2017. PMID: 29120023
-
Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease.Semin Hematol. 2001 Jan;38(1 Suppl 1):37-56. doi: 10.1016/s0037-1963(01)90059-9. Semin Hematol. 2001. PMID: 11206960 Review.
Cited by
-
Effect of deferasirox chelation on liver iron and total body iron concentration.Indian J Pediatr. 2013 Aug;80(8):655-8. doi: 10.1007/s12098-013-1030-y. Epub 2013 May 29. Indian J Pediatr. 2013. PMID: 23715791
-
Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications.Int J Mol Sci. 2023 Aug 18;24(16):12928. doi: 10.3390/ijms241612928. Int J Mol Sci. 2023. PMID: 37629109 Free PMC article. Review.
-
MRI guided iron assessment and oral chelator use improve iron status in thalassemia major patients.Am J Hematol. 2014 Jul;89(7):684-8. doi: 10.1002/ajh.23715. Epub 2014 Apr 10. Am J Hematol. 2014. PMID: 24652616 Free PMC article.
-
Age modulates Fe3O4 nanoparticles liver toxicity: dose-dependent decrease in mitochondrial respiratory chain complexes activities and coupling in middle-aged as compared to young rats.Biomed Res Int. 2014;2014:474081. doi: 10.1155/2014/474081. Epub 2014 May 6. Biomed Res Int. 2014. PMID: 24949453 Free PMC article.
-
Reproducibility of liver iron concentration estimates in MRI through R2* measurement determined by least-squares curve fitting.J Appl Clin Med Phys. 2020 Dec;21(12):295-303. doi: 10.1002/acm2.13096. Epub 2020 Nov 18. J Appl Clin Med Phys. 2020. PMID: 33207043 Free PMC article.
References
-
- Ehlers KH, Giardina PJ, Lesser ML, et al. Prolonged survival in patients with β-thalassemia major treated with deferoxamine. J Pediatr. 1991;118(4 Part 1):540–545. - PubMed
-
- Hershko C. Oral iron chelators: New opportunities and new dilemmas. Haematologica. 2006;91:1307–1312. - PubMed
-
- Modell B, Khan M, Darlison M. Survival in β thalassaemia major in the UK: Data from the UK Thalassaemia Register. Lancet. 2000;355:2051–2052. - PubMed
-
- Zurlo MG, De Stefano P, Borgna-Pignatti C, et al. Survival and causes of death in thalassaemia major. Lancet. 1989;2:27–30. - PubMed
-
- Cappellini MD, Vermylen C, Gathmann I, Ford JM. Body iron balance and iron excretion: Intake ratio, according to transfusional requirements, during treatment with the once-daily oral iron chelator deferasirox (EXJADE®, ICL670) Haematologica. 2006;91(Suppl 1) Abstract 16.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical